Cardiovascular
1 drug is in development for Atherosclerotic Cardiovascular Disease.
- Companies
- 1
- Clinical trials
- 19
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Atherosclerotic Cardiovascular Disease pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| verve-101 | Verve Therapeutics, Inc. (VERV) |
About this indication
Atherosclerotic Cardiovascular Disease context
Cardiovascular·MeSH: Atherosclerosis (D050197)
Narrower concept of MeSH descriptor Atherosclerosis
Prevalence
6000.0 / 100K
Incidence
500.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Atherosclerotic Cardiovascular Disease?
BioSniper tracks 1 drug in development for Atherosclerotic Cardiovascular Disease across 1 company.
How many clinical trials target Atherosclerotic Cardiovascular Disease?
There are 19 clinical trials targeting Atherosclerotic Cardiovascular Disease tracked by BioSniper.
What is the prevalence of Atherosclerotic Cardiovascular Disease?
The estimated prevalence of Atherosclerotic Cardiovascular Disease is approximately 6000.0 per 100,000 population.